Evidence map›Paper›PMID 34777751›Full record

ArticleChemical science2021

Chemoselective cysteine or disulfide modification

Lujuan Xu, Maria J S A Silva, Pedro M P Gois, Seah Ling Kuan, Tanja Weil

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. RSC chemical biology · 2023
    Article
  9. Article
  10. Article
  11. Fast Cysteine Bioconjugation Chemistry.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  12. Divinylpyrimidine reagents generate antibody-drug conjugates with excellentChemical communications (Cambridge, England) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Lujuan XuMax Planck Institute for Polymer Research Ackermannweg 10 55128 Mainz Germany weil@mpip-mainz.mpg.de.
Maria J S A SilvaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa 1649-003 Lisbon Portugal.ORCID https://orcid.org/0000-0003-4178-1942
Pedro M P GoisResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa 1649-003 Lisbon Portugal.ORCID https://orcid.org/0000-0002-7698-630X
Seah Ling KuanMax Planck Institute for Polymer Research Ackermannweg 10 55128 Mainz Germany weil@mpip-mainz.mpg.de.ORCID https://orcid.org/0000-0003-3945-4491
Tanja WeilMax Planck Institute for Polymer Research Ackermannweg 10 55128 Mainz Germany weil@mpip-mainz.mpg.de.ORCID https://orcid.org/0000-0002-5906-7205
Universität Ulm · DEUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of bioconjugation chemistry has enabled the combination of various synthetic functionalities to proteins, giving rise to new classes of protein conjugates with functions well beyond what Nature can provide. Despite the progress in bioconjugation chemistry, there are no reagents developed to date where the reactivity can be tuned in a user-defined fashion to address different amino acid residues in proteins. Here, we report that 2-chloromethyl acryl reagents can serve as a simple yet versatile platform for selective protein modification at cysteine or disulfide sites by tuning their inherent electronic properties through the amide or ester linkage. Specifically, the 2-chloromethyl derivatives (acrylamide or acrylate) can be obtained

Identifiers

PMID34777751
PMCPMC8528048
OpenAlexW3200899939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.